The Centers for Disease Control and Prevention finalized its guidelines for post-exposure prophylaxis against bacterial sexually transmitted infections on Tuesday. For groups at higher risk
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. We’ll resume for ASCO
But in the hearing room Tuesday, Republicans accused Democrats of “fear-mongering” over restrictive laws and pointed to states’ exceptions to save the life of the
The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or
Researchers from the University of Oslo have developed an innovative tool that promises to improve our understanding of heritable human traits and diseases.
Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.
A recent study from the University of Toronto has revealed critical insights into the use of muscle-building supplements (such as whey protein and creatine) among
Amid rising concern over prescription drug shortages, a new report finds that the number of shortages has increased over the past decade, most are lasting
Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse
What You Should Know: – Sword Health, a pioneer in AI-powered healthcare delivery, announced a $130M financing round today bringing Sword’s total funding to $340M